When intratumoral CD4/CD8 ratio and peritumoral CD4/CD8 ratio were evaluated within the groups, statistical significance was observed only in study group with NSCLC subtype (p = 0.0499) (Table 2). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.